Can friends help stop HIV? new trial uses peer power to promote prevention and treatment

NCT ID NCT07409350

Not yet recruiting Prevention Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a social network approach can encourage people who inject drugs to start HIV prevention medication (PrEP) and addiction treatment (MOUD). About 398 participants will be assigned to either the LINKED intervention or a control group. The goal is to see if peer influence and group discussions increase uptake and adherence to these life-saving treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (social network approach and group sessions)
What this could lead to: If successful, this could provide a low-cost, community-driven way to increase HIV prevention and addiction treatment in high-risk groups.
What could go wrong: This is a behavioral study, not a drug trial, so results depend on social dynamics and may not be easy to replicate elsewhere. It is still recruiting and has not yet started.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

substance abuse substance-related disorder HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION SUBSTANCE USE

Contacts and locations

Locations

NYU Langone Health

New York, New York, 10016, United States
The University of Chicago

Chicago, Illinois, 60637, United States
University of Southern California

Los Angeles, California, 90033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.